Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EOG | Common Stock | Options Exercise | $347K | +5K | +7.24% | $69.43 | 74K | Mar 21, 2022 | Direct | |
transaction | EOG | Common Stock | Disposed to Issuer | -$347K | -2.85K | -3.85% | $121.92 | 71.2K | Mar 21, 2022 | Direct | |
transaction | EOG | Common Stock | Tax liability | -$63.9K | -524 | -0.74% | $121.92 | 70.7K | Mar 21, 2022 | Direct | |
transaction | EOG | Common Stock | Sale | -$199K | -1.63K | -2.3% | $121.95 | 69K | Mar 21, 2022 | Direct | |
transaction | EOG | Common Stock | Sale | -$251K | -2.06K | -2.98% | $121.96 | 67K | Mar 21, 2022 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EOG | Stock Appreciation Rights | Options Exercise | $0 | -5K | -58.82% | $0.00 | 3.5K | Mar 21, 2022 | Common Stock | 5K | $69.43 | Direct | F1 |
Id | Content |
---|---|
F1 | The SARs granted became exercisable in 25 percent increments beginning one year from the September 28, 2015 date of grant and on each of the next three grant date anniversaries. The SARs granted became fully exercisable on September 28, 2019. |